Aptevo Therapeutics Stock (NASDAQ: APVO) stock price, news, charts, stock research, profile.
You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.
Other companies in Aptevo Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN) and Dermata Therapeutics (NASDAQ:DRMA).
Aptevo Therapeutics has a consensus price target of $14.00.
The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $3.3161 last updated February 21, 2025 at 10:06 AM EST.
There are no upcoming dividends for Aptevo Therapeutics.
Aptevo Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for Aptevo Therapeutics.
Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.